Genelux (GNLX) Accumulated Expenses (2022 - 2026)

Genelux (GNLX) recorded quarterly Accumulated Expenses of $861000.0 in Q1 2026, down 40.21% quarter-over-quarter from $1.4 million in Q4 2025.

Genelux (GNLX) Accumulated Expenses (2022 - 2026) Analysis & Trends

Genelux's Accumulated Expenses history runs 5 years deep, the most recent figure standing at $861000.0 for Q1 2026.

  • In Q1 2026, Accumulated Expenses changed N/A year-over-year to $861000.0; the TTM figure through Mar 2026 stood at $861000.0 (changed N/A YoY), while the FY2025 annual figure was $1.4 million, down 78.1% from the prior year.
  • Accumulated Expenses was $861000.0 for Q1 2026 at Genelux, down from $1.4 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $6.6 million in Q4 2024 to a low of $517000.0 in Q2 2024.
  • Historically, Accumulated Expenses has averaged $1.9 million across 5 years, with a median of $1.2 million in 2022.
  • Biggest YoY gain for Accumulated Expenses was 210.53% in 2024; the steepest drop was 83.27% in 2024.
  • A 5-year view of Accumulated Expenses shows it stood at $1.2 million in 2022, then jumped by 79.71% to $2.1 million in 2023, then jumped by 210.53% to $6.6 million in 2024, then sank by 78.1% to $1.4 million in 2025, then sank by 40.21% to $861000.0 in 2026.
  • The last three Accumulated Expenses figures came in at $861000.0 (Q1 2026), $1.4 million (Q4 2025), and $800000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Genelux 129.36 Mn 129.36 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 861,000.00
Dec 31, 2025 1.44 Mn
Sep 30, 2025 800,000.00
Jun 30, 2025 610,000.00
Dec 31, 2024 6.57 Mn
Sep 30, 2024 686,000.00
Jun 30, 2024 517,000.00
Mar 31, 2024 1.91 Mn
Dec 31, 2023 2.12 Mn
Sep 30, 2023 4.10 Mn
Dec 31, 2022 1.18 Mn